SEGMENT AND GEOGRAPHIC INFORMATION - Financial Information of Segments (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 2,753	$ 2,699	$ 2,694	$ 2,490	$ 2,729	$ 2,599	$ 2,591	$ 2,441	$ 10,636	$ 10,360	$ 10,057
United States
Segment Reporting Information [Line Items]
Net sales									5,850	5,802	5,769
Non-US
Segment Reporting Information [Line Items]
Net sales									4,786	4,558	4,288
Other | Revision of Prior Period, Adjustment
Segment Reporting Information [Line Items]
Net sales								2			37
BPS | Revision of Prior Period, Adjustment
Segment Reporting Information [Line Items]
Net sales								$ (2)			(37)
Operating Segments | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									5,207	5,011	4,815
Operating Segments | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									2,951	3,013	2,939
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									2,411	2,249	2,126
Operating Segments | United States | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									2,882	2,809	2,815
Operating Segments | United States | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									2,154	2,168	2,135
Operating Segments | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									780	759	682
Operating Segments | Non-US | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									2,325	2,202	2,000
Operating Segments | Non-US | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									797	845	804
Operating Segments | Non-US | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									1,631	1,490	1,444
Operating Segments | Infusion Therapies & Technologies | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									4,103	3,960	3,817
Operating Segments | Infusion Therapies & Technologies | United States | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									2,279	2,227	2,241
Operating Segments | Infusion Therapies & Technologies | Non-US | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									1,824	1,733	1,576
Operating Segments | Advanced Surgery | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									1,104	1,051	998
Operating Segments | Advanced Surgery | United States | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									603	582	574
Operating Segments | Advanced Surgery | Non-US | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales									501	469	424
Operating Segments | Care and Connectivity Solutions | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									1,814	1,800	1,791
Operating Segments | Care and Connectivity Solutions | United States | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									1,311	1,263	1,295
Operating Segments | Care and Connectivity Solutions | Non-US | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									503	537	496
Operating Segments | Front Line Care | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									1,137	1,213	1,148
Operating Segments | Front Line Care | United States | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									843	905	840
Operating Segments | Front Line Care | Non-US | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales									294	308	308
Operating Segments | Injectables and Anesthesia | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									1,373	1,347	1,305
Operating Segments | Injectables and Anesthesia | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									780	759	682
Operating Segments | Injectables and Anesthesia | Non-US | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									593	588	623
Operating Segments | Drug Compounding | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									1,038	902	821
Operating Segments | Drug Compounding | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									0	0	0
Operating Segments | Drug Compounding | Non-US | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales									1,038	902	821
Other
Segment Reporting Information [Line Items]
Net sales									67	87	177
Other | United States
Segment Reporting Information [Line Items]
Net sales									34	66	137
Other | Non-US
Segment Reporting Information [Line Items]
Net sales									$ 33	$ 21	$ 40